Croce (10) first reported three cases with COL1A1–PDGFB fusion in uterine sarcomas in 2019, and subsequently, Samuel and Adriana respectively reported one case each in 2020 and 2022 (11, 12). Here, COL1A1 is linked to uterine corpus sarcoma.